Skip to main content

Are cancer patients better off if they participate in clinical trials?

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.


Articles

Featured video: Microparticles, breast cancer's secret weapon?

Your browser needs to have JavaScript enabled to view this video

Read the article

Welcome

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials.

Call for Submissions: 'Microbiome and Cancer' Collection

The Editors of BMC Cancer and BMC Microbiology invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley and Dr. Sean Devlin. Open for submissions until 1st May 2021. 


Support and Guidance

Planning to submit a systematic review?

Prof Kelley provides a practical and stepwise approach for systematically reviewing the literature and publishing the results here

Submitting a study protocol?

Find out more about the journal's criteria and scope for study protocols here

BMC Series Focus Issues

April: Our Changing Environment

In preparation for Earth Day on 22nd April, the BMC Series presents a focus issue on Our Changing Environment, highlighting research from across the journals on climate change, conservation, pollution, and the impact of environmental changes on human health and disease.

March: Rare diseases

With the 28th of February marking World Rare Diseases day, the BMC Series this month looks at highlighting research on the Rare diseases that together affect around 10% of the population. Read the full collection of articles here.

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last 6 months!

Editorial: Nobel Prize Cancer Immunotherapy!

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Speed
    79 days to first decision for reviewed manuscripts only
    55 days to first decision for all manuscripts
    170 days from submission to acceptance
    16 days from acceptance to publication

    Citation Impact
    3.15 -   2-year Impact Factor
    3.432 - 5-year Impact Factor
    1.021 - Source Normalized Impact per Paper (SNIP)
    1.186 - SCImago Journal Rank (SJR)

    Usage 
    5,089,371 Downloads
    2,117 Altmetric Mentions

\